Report Highlights

U.S. Anti-Tacking Agents: Market Overview

The U.S. anti-tacking agents market, valued at USD 412 million in 2024, is built on a food-first demand base in which processed food and beverage manufacturers account for roughly 60 percent of consumption. Silicon dioxide, calcium silicate and tricalcium phosphate dominate because iodized table salt, powdered seasonings and dry mixes must remain free-flowing through humid distribution chains. Domestic demand therefore tracks packaged food output rather than industrial construction or plastics, which shapes buyer behavior and pricing.

Unlike the global norm, where Asia Pacific supplies most precipitated silica, U.S. production is concentrated in a small group of plants run by Evonik Industries, PQ Corporation and Cabot Corporation, with Innophos supplying phosphate-based grades. Import dependence is low for food-grade silica but higher for talc and specialty magnesium stearate, which exposes buyers to tariff and certification shocks. Supply reliability, not price, is the decisive purchasing criterion for most salt and seasoning producers.

Growth Drivers for U.S. Anti-Tacking Agents

Protein and sports nutrition powders are the fastest-growing application. U.S. retail sales of powdered protein supplements exceeded USD 5 billion in 2023 by industry estimates, and formulators across the category rely on silicon dioxide to prevent clumping in humid warehouses and gym-channel displays. Each dosing scoop requires consistent flow, which makes powders more silica-intensive than most dry food categories. Growth in this category has outpaced packaged food volume growth for three consecutive years.

Sodium reduction is the second driver. FDA's voluntary sodium reduction targets push processors toward potassium chloride blends, which absorb moisture more readily than sodium chloride and cake faster. Processors therefore raise calcium silicate and silica loads in seasoning lines. Pharmaceutical tableting adds steady demand for USP-grade magnesium stearate and colloidal silicon dioxide among U.S. generic manufacturers, with much of that volume concentrated in New Jersey and Indiana.

Restraints and Entry Barriers in the U.S. Market

FDA food additive status is the central barrier. Anti-tacking substances must hold GRAS status under 21 CFR Part 182 or a specific listing under 21 CFR Part 172, with silicon dioxide approved under 21 CFR 172.480. FDA's 2025 plan to eliminate self-affirmed GRAS determinations would force new entrants into formal notifications that typically take 18 to 24 months to clear.

Talc-based agents face asbestos testing scrutiny and California Proposition 65 warning obligations, while tariffs on Chinese precipitated silica raise landed costs for importers. Incumbents Evonik and PQ Corporation hold multi-year supply contracts with large salt and seasoning producers, leaving sub-scale entrants limited shelf space. Distributors such as Brenntag add margin pressure on every transaction. Smaller blenders therefore pay the highest per-unit cost of compliance.

Market Opportunities in the United States

Plant-based cheese and non-dairy creamer powders form a near-term opening. Plant-based shredded cheese volumes are growing faster than dairy cheese, and their anti-caking requirements are higher because starch and fat-free blends clump in transit. Analyst estimates place the addressable anti-tacking pool in these categories at USD 35 million by 2028, which entrants can capture through blender partnerships.

Domestic substitution for imported talc and stearates is the second opening. U.S. pharmaceutical excipient demand for anti-tacking grades is estimated at USD 60 million annually, and buyers facing Section 301 tariffs on Chinese inputs favor qualified U.S. plants in New Jersey, Ohio and Illinois. A producer securing an FDA Drug Master File could win excipient contracts from generic manufacturers within two years.

Market at a Glance

Leading Market Participants

• Evonik Industries
• PQ Corporation
• Cabot Corporation
• Innophos
• Imerys
• Huber Engineered Materials
• Minerals Technologies
• Brenntag
• Univar Solutions
• Cargill

Regulatory and Policy Environment

The Federal Food, Drug, and Cosmetic Act governs food-grade anti-tacking agents, with FDA administering GRAS notifications and food additive petitions under 21 CFR Parts 172 and 182. The Food Safety Modernization Act of 2011 imposes preventive controls on food facilities, and FDA's Food Traceability Rule compliance date has been extended to July 20, 2028, giving blenders additional time to build lot-level records. Pharmaceutical grades must meet United States Pharmacopeia monographs and Current Good Manufacturing Practice requirements under 21 CFR Part 211.

Trade policy shapes import economics. USTR Section 301 tariffs apply to many Chinese chemical inputs, and U.S. Customs and Border Protection enforces classification rulings that determine duty rates on precipitated silica and talc. California Proposition 65 requires warnings for listed chemicals, and state-level scrutiny of food additives is rising. Direct federal subsidies for anti-tacking production are absent, although the Department of Energy's Industrial Efficiency and Decarbonization Office funds process electrification at mineral processing plants.

Long-Term Outlook for Anti-Tacking Agents in the U.S.

By 2032, the U.S. market is projected to reach USD 610 million at a 5.0 percent CAGR, with growth concentrated in powdered nutrition, plant-based dairy alternatives and pharmaceutical excipients. Silica and calcium silicate will retain the largest share, while phosphate-based grades grow more slowly as processors shift toward silica-based systems. Talc's share will shrink as testing and labeling requirements tighten.

Consolidation among domestic silica producers and tighter GRAS rules will favor incumbents with established regulatory dossiers. Buyers that secure domestic supply and qualified blending partners now will hold cost advantages through 2032, while entrants without notification pipelines face a longer path to revenue. Distribution control will remain the decisive competitive lever across the forecast period.